Notice of Registration - 2011
[Federal Register Volume 76, Number 27 (Wednesday, February 9, 2011)]
[Notices]
[Page 7234]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-2826]
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated October 8, 2010 and published in the Federal
Register on October 20, 2010, 75 FR 64745, Noramco, Inc., 500 Swedes
Landing Road, Wilmington, Delaware 19801-4417, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as a bulk manufacturer of the following basic classes of controlled
substances:
| Drug |
Schedule |
| Codeine-N-oxide (9053) |
I |
| Dihydromorphine (9145) |
I |
| Morphine-N-oxide (9307) |
I |
| Methylphenidate (1724) |
II |
| Codeine (9050) |
II |
| Dihydrocodeine (9120) |
II |
| Oxycodone (9143) |
II |
| Hydromorphone (9150) |
II |
| Hydrocodone (9193) |
II |
| Morphine (9300) |
II |
| Thebaine (9333) |
II |
| Opium extracts (9610) |
II |
| Opium fluid extract (9620) |
II |
| Opium tincture (9630) |
II |
| Opium, powdered (9639) |
II |
| Opium, granulated (9640) |
II |
| Oxymorphone (9652) |
II |
| Noroxymorphone (9668) |
II |
| Tapentadol (9780) |
II |
The company plans to manufacture the listed controlled substances
in bulk for distribution to its customers.
No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and determined that the registration of
Noramco, Inc. to manufacture the listed basic classes of controlled
substances is consistent with the public interest at this time. DEA has
investigated Noramco, Inc. to ensure that the company's registration is
consistent with the public interest. The investigation has included
inspection and testing of the company's physical security systems,
verification of the company's compliance with state and local laws, and
a review of the company's background and history. Therefore, pursuant
to 21 USC Sec. 823(a), and in accordance with 21 CFR Sec. 1301.33,
the above named company is granted registration as a bulk manufacturer
of the basic classes of controlled substances listed.
Dated: February 2, 2011.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. 2011-2826 Filed 2-8-11; 8:45 am]
BILLING CODE 4410-09-P
NOTICE: This is an unofficial version. An official version of this publication may be obtained
directly from the Government Printing Office (GPO). |
